Selected Auger Electron-Emitting Radionuclides for Therapeutic Nuclear Medicine
Auger electron-emitting radionuclides offer innovative therapeutic potential through highly localised DNA damage with minimal collateral effects.
Auger electron-emitting radionuclides offer innovative therapeutic potential through highly localised DNA damage with minimal collateral effects.
Ankylosing Spondylitis is a progressive inflammatory condition targeting the spine, leading to chronic pain and joint fusion.
Lead-212 ADVC001 offers innovative alpha-emitting therapy, targeting PSMA-positive mCRPC with precise and potent tumour eradication.
RBE in proton therapy quantifies biological damage relative to conventional radiation, enhancing treatment precision significantly.
Targeted radionuclide therapy was first used to treat cancer for an ‘over-active’ thyroid using radioactive iodine-131 seeds.